Swiss biotech company Planetary has raised €34 million, combining Series A equity financing and credit. Its BioBlocks technology platform turns sugar and side streams into biobased mycoproteins, fibres and enzymes. Founded in 2021, the start-up has an industrial production line running in Aarberg, Switzerland. Its business model is to build, own and operate fermentation facilities globally as well as to license its technology to sugar companies. This would allow them to add an additional revenue stream by supplying biotech proteins, polymers or enzymes. 

Planetary focuses on both precision fermentation and biomass processes. 

Share this story: